HealthCare Global Reports FY26 Financial Results

HealthCare Global Enterprises Ltd. announced its audited financial results for the fourth quarter and full year ended March 31, 2026. The Board of Directors approved these results on May 19, 2026, with the company publishing them via newspaper advertisements on May 21, 2026.

Income Rises, Profit Suffers Due to Exceptional Items

Investors closely follow financial results to assess a company's performance. HealthCare Global's total income saw an increase for both the quarter and the full year. However, net profit after exceptional items dropped considerably. For the fourth quarter, net profit fell to Rs 404 lakh from Rs 677 lakh in the previous year. For the full fiscal year, net profit after exceptional items declined to Rs 2,278 lakh from Rs 4,883 lakh in FY25. This decline in profitability, coupled with a significant decrease in Earnings Per Share (EPS), is a key concern for shareholders.

Audited Results Provide Financial Snapshot

This announcement covers the financial performance for the fiscal year 2025-2026. The results have been audited by statutory auditors, offering a verified view of the company's financial health. The figures for the quarters are based on audited full-year results and limited-review third-quarter figures.

Impact on Shareholders and Future Decisions

The audited results offer a clear picture of the company's financial standing for FY26. This information will help shareholders evaluate their investments. The reported figures are likely to influence future investment decisions and the market's perception of the company.

Key Financial Metrics

Consolidated Financials (Quarter ended March 31):

• Total Income: Rs 66,540 lakh (FY26) vs Rs 59,539 lakh (FY25)
• Net Profit (before exceptional items): Rs 3,316 lakh (FY26) vs Rs 1,362 lakh (FY25)
• Net Profit (after exceptional items): Rs 404 lakh (FY26) vs Rs 677 lakh (FY25)
• Basic EPS: Rs 0.15 (FY26) vs Rs 0.52 (FY25)

Consolidated Financials (Full Year ended March 31):

• Total Income: Rs 257,040 lakh (FY26) vs Rs 225,766 lakh (FY25)
• Net Profit (before exceptional items): Rs 7,150 lakh (FY26) vs Rs 5,696 lakh (FY25)
• Net Profit (after exceptional items): Rs 2,278 lakh (FY26) vs Rs 4,883 lakh (FY25)
• Basic EPS: Rs 0.97 (FY26) vs Rs 3.17 (FY25)

Standalone Financials (Quarter ended March 31):

• Total Income: Rs 36,513 lakh (FY26) vs Rs 33,384 lakh (FY25)
• Net Profit (before exceptional items): Rs 3,857 lakh (FY26) vs Rs 1,680 lakh (FY25)
• Net Profit (after exceptional items): Rs 153 lakh (FY26) vs Rs 1,015 lakh (FY25)
• Basic EPS: Rs 0.11 (FY26) vs Rs 0.71 (FY25)

Standalone Financials (Full Year ended March 31):

• Total Income: Rs 139,497 lakh (FY26) vs Rs 131,510 lakh (FY25)
• Net Profit (before exceptional items): Rs 6,500 lakh (FY26) vs Rs 5,440 lakh (FY25)
• Net Profit (after exceptional items): Rs 1,458 lakh (FY26) vs Rs 353 lakh (FY25)
• Basic EPS: Rs 1.03 (FY26) vs Rs 0.25 (FY25)

What to Watch Next

Investors will be looking for management's commentary on the specific reasons behind the decline in net profit after exceptional items and the company's outlook for future profitability. Monitoring HealthCare Global's ability to manage these one-off costs and improve its EPS will be critical for its stock performance.